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EditorialAdvancing Stem Cell Science and TranslationSean Morrison, ISSCR President, 2015–2016Stem cell research remains an exploding area of investiga-
tion with the potential to change human health. As the
field continues to grow, so does the ISSCR and its role as
the world’s largest professional organization of stem cell
scientists. Our mission to promote good science and
responsible clinical translation has never been as impor-
tant as it is today.
In all areas of stem cell science and translation, the ISSCR
seeks to promote best practices and high standards, and
the ISSCR’s recently published ‘‘Guidelines for Stem Cell
Research and Clinical Translation’’ will be instrumental
for researchers around the world (http://www.isscr.org/
guidelines2016). These guidelines are the culmination
of 2 years of work from an ISSCR task force of scientists,
bioethicists, and clinical researchers. Under the leadership
of bioethicist Jonathan Kimmelman and board member
George Daley, the task force reviewed and updated the
ISSCR’s ‘‘Guidelines for the Conduct of Human Embryonic
Stem Cells’’ (2006) and ‘‘Guidelines for the Clinical Trans-
lation of Stem Cells’’ (2008). At the ISSCR’s 2015 meeting
in Stockholm, the ISSCR presented a draft document of
the updated guidelines and in the following months soli-
cited feedback from many stakeholders around the world,
including scientific societies, regulatory authorities, pa-
tient advocacy organizations, and funding agencies. The
result—the ‘‘ISSCR’s Guidelines for Stem Cell Research
and Clinical Translation’’ (2016)—offers a set of standards
that achieve rigor, appropriate oversight, and transparency
in all aspects of stem cell research, as well as protecting pa-
tient welfare and promoting social justice. In Daley et al.
(pp. 787–797) in this issue of StemCell Reports, the task force
highlights the core principles embodied in the guidelines
and outlines key deliberations and recommendations. We
look forward to continuing the dialog on these issues that
are central to our goal of improving human health through
stem cell research.
Delivering the promise of stem cell research to the public
will require the involvement of many stakeholders. The
ISSCR has been working to strengthen interactions with
relevant groups outside of the academic scientific commu-
nity, including entrepreneurs, investors, biotech com-
panies, pharmaceutical companies, and the philanthropic
community. In January of this year, working with the soci-
ety’s Global Advisory Council, we brought representatives
of these groups togetherwith ISSCR leaders for an inaugural
‘‘Nucleus Forum’’ to explore the disruptive and transforma-
tive technologies that are likely to arise in the next 10 years.
Over the past year, the ISSCR also launched a public pol-
icy program that will allow the ISSCR to play a leadershipThis is an open access article under the Crole in supporting the ability of researchers worldwide to
perform stem cell research and to translate that research
to benefit patients. We were delighted to welcome Policy
Director Kevin Wilson to the ISSCR staff. Kevin served as
policy director for the American Society for Cell Biology
for 14 years and is a veteran of stem cell policy battles in
the United States. You may have seen the policy briefings
that Kevin sends out every few weeks, keeping the ISSCR
membership abreast of policy developments that affect
the stem cell and regenerative medicine communities
worldwide.Wehave also formulated an ISSCR Public Policy
Committee that works with Kevin to identify policy issues
around theworldwhichhave the potential to influence our
field or our ability to efficiently and rigorously translate
good science. Kevin then works with the membership to
educate policy makers as they craft effective legislation.
Although it is only 9 months old, the ISSCR policy effort
has been very active.We developed a policy endorsing fetal
tissue research, an area of research under threat in the
United States. A member of the ISSCR Public Policy com-
mittee, Larry Goldstein, testified before the United States
Congress on Capitol Hill. We have also engaged with
policy makers in the United States regarding legislation
that would overhaul Food and Drug Administration
regulation of cell therapies and with policy makers in theStem Cell Reports j Vol. 6 j 785–786 j June 14, 2016 j ª 2016 785
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delivery of new therapeutics. Our policy programwill allow
the ISSCR to play a leadership role in advocating for pol-
icies that promote integrity in biomedical research and
ensure stem cell treatments are safe and effective before
they are sold to patients. As these efforts move forward,
we can expect additional engagement by the ISSCR in pol-
icy matters around the globe.
In concert with the new policy initiative, we are also
overhauling our communications program. Anne Nicholas
joined the ISSCR in April as senior communications man-
ager. She previously served as director of media and com-
munications for the Society for Neuroscience and in a
number of communications management roles at the
American Bar Association. Anne has a background in
broadcast journalism and was a producer and on-air host
on C-SPAN. In her short time at the ISSCR, she has success-
fully released the ISSCR guidelines to the press and devel-
oped the press program at the annualmeeting. I am pleased
to report that news about the guidelines was picked up by
media outlets around the world, including in China, India,
South Korea, Australia, Europe, and North America, and we
continue to see articles that refer to the new guidelines.
Anne will continue to encourage balanced communica-
tions about the promise of new stem cell research and ther-
apies so the public can have appropriate expectations. In
addition, Anne will be building and streamlining member
and field-facing communications to increase the value we
provide to members.
The communications program will take advantage of
ever-growing media channels that can help reach new au-
diences around the globe. The ISSCR will continue to
expand its social media presence, engaging with members,
the field, and the public in a variety of formats that
encourage sharing important science news and informa-
tion about our work. In the coming year, the ISSCR will
introduce a redesigned website that will serve as a key
source of information about the society and its support
for members and the field.
The public-facing informational website, ‘‘A Closer Look
at Stem Cells’’ (http://www.closerlookatstemcells.org),
plays a central role in ISSCR’s communications efforts.
Launched with new content and a new look in April
2015, the site provides key background information for786 Stem Cell Reports j Vol. 6 j 785–786 j June 14, 2016the public about stem cell science and its translational
applications. This month, the ISSCR launched a Spanish-
language page within the ‘‘A Closer Look at Stem Cells’’
website that offers many of the website’s resources, making
information about stem cell science and medicine acces-
sible to a wider international audience. Increasingly, the
site is promoted to the media as a source of information
and to the public via social media and other channels.
These efforts will continue and will focus on growing
audiences around the globe.
Stem Cell Reports is another arm of the ISSCR’s efforts to
provide voice and visibility to progress in the field. I would
like to acknowledge the driving force behind the journal,
Editor-in-Chief Christine Mummery; Associate Editors,
past and present, Nissim Benvenisty, Thomas Graf, Hide-
yuki Okano, David Scadden, and AmyWagers; andManag-
ing Editor Yvonne Fischer. I congratulate them on their
delivery of strong editorial leadership, providing fast and
fair review and publication of well-documented stem cell
research and its applications.
With this issue of Stem Cell Reports, we honor Paolo
Bianco (1955–2015), a member of the recent ISSCR guide-
lines effort, a co-recipient of the 2014 ISSCR Public Service
Award, and a staunch supporter of rigor in science and
accurate communication. In this issue is an article by
Riminucci, Robey, Bianco, and colleagues that celebrates
Paolo’s legacy by clarifying the potential of mesenchymal
stromal cells from different tissues in vivo (Sachetti et al.,
pp. 897–913).
This year marks the tenth anniversary of induced plurip-
otent stem cells (iPSCs). In this issue, you will find a diverse
range of research articles using iPSCs, including descrip-
tions of an enhanced reprogramming mechanism, disease
modeling, and directed differentiation for therapeutic pur-
pose, that demonstrate the far-reaching implications of
this breakthrough technology.
We hope you enjoy the research presented within these
pages and pause to reflect on the tremendous progress we
have made over the past 10 years as well as what we can
accomplish over the next 10 years.Sean Morrison, PhD
ISSCR President, 2015–2016
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